Welcome to our dedicated page for Jin Medical news (Ticker: ZJYL), a resource for investors and traders seeking the latest updates and insights on Jin Medical stock.
Jin Medical International Ltd. reports developments tied to its rehabilitation medical equipment business, including wheelchair and living-aid products for people with disabilities, elderly users and rehabilitation applications. The company designs, develops, manufactures and markets mobility products, with wheelchair models sold through distributors in China, Japan and other international markets.
Recurring news for ZJYL includes updates on manufacturing capacity in China, including the Chuzhou facility and Class I Medical Device production licensing, as well as management communications on strategy and capital structure. Company announcements also cover Nasdaq listing compliance, the completed share combination, and the reclassification of ordinary shares into Class A and Class B ordinary shares.
Jin Medical International Ltd. (NASDAQ: ZJYL) announced the partial exercise of the over-allotment option by Prime Number Capital, LLC, resulting in the purchase of 47,355 ordinary shares at $8.00 per share. This adds $378,840 to the IPO's gross proceeds, which now total $8,378,840 before offering expenses. The IPO, facilitated by Prime Number Capital as the sole bookrunner, was declared effective by the SEC on March 27, 2023. The company operates in the wheelchair and living aids sector, with established manufacturing plants and relationships with over 40 distributors.
Along with its IPO announcement, the company highlighted its manufacturing capabilities and innovative product designs, holding over 100 patents and continually enhancing product offerings for market competitiveness.
Jin Medical International Ltd. (NASDAQ: ZJYL) has successfully closed its initial public offering (IPO) on March 30, 2023, raising $8 million from the sale of 1,000,000 ordinary shares at $8.00 per share. The underwriters have an option to purchase an additional 150,000 shares for over-allotments. Proceeds from the offering will be allocated to various initiatives including R&D, marketing, and production capacity enhancements, as well as potential acquisitions. Shares began trading on the Nasdaq Capital Market on March 28, 2023. The company operates in the wheelchair and living aids sector, with established market connections in China and Japan.
Jin Medical International Ltd. (NASDAQ: ZJYL) has announced the pricing of its initial public offering (IPO) of 1,000,000 ordinary shares at $8.00 per share, totaling $8,000,000 in gross proceeds. The IPO is set to close on March 30, 2023, and shares will trade on Nasdaq beginning March 28, 2023. The underwriters have an option to purchase an additional 150,000 shares. Proceeds will be used for research and development, marketing, production capacity expansion, acquisitions, and general corporate purposes. The company operates two manufacturing plants in China and focuses on products for individuals with disabilities and the elderly.